Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg M Delgoffe

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Mbio|September 29, 2023
Antiviral epithelial-macrophage crosstalk permits secondary bacterial infectionsSidney Lane, Tristan L A White, Erin E Walsh, et al.
Oncoimmunology|February 21, 2020
Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironmentMin Yang, Wenwen Du, Lixian Yi, et al.
Science Immunology|August 5, 2022
Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cellsB Rhodes Ford, Paolo D A Vignali, Natalie L Rittenhouse, et al.
Cell Reports|February 10, 2018
Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector FunctionsAshley V Menk, Nicole E Scharping, Rebecca S Moreci, et al.
JCI Insight|February 22, 2023
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapyFrank P Vendetti, Pinakin Pandya, David A Clump, et al.
Immunity|August 7, 2016
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell ExhaustionBertram Bengsch, Andy L Johnson, Makoto Kurachi, et al.
Immunity|February 14, 2016
Interleukin-35 Limits Anti-Tumor ImmunityMeghan E Turnis, Deepali V Sawant, Andrea L Szymczak-Workman, et al.
Immunity|September 1, 2019
Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor ClearanceDayana B Rivadeneira, Kristin DePeaux, Yiyang Wang, et al.
Frontiers in Oncology|July 3, 2023
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional studyRyan C Augustin, Ziyu Huang, Fei Ding, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2024
Tim-3 Is Required for Regulatory T Cell-Mediated Promotion of T Cell Exhaustion and Viral Persistence during Chronic Lymphocytic Choriomeningitis Virus InfectionHector M Nieves-Rosado, Hridesh Banerjee, Angela Gocher-Demske, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Mbio|September 29, 2023
Antiviral epithelial-macrophage crosstalk permits secondary bacterial infectionsSidney Lane, Tristan L A White, Erin E Walsh, et al.
Oncoimmunology|February 21, 2020
Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironmentMin Yang, Wenwen Du, Lixian Yi, et al.
Science Immunology|August 5, 2022
Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cellsB Rhodes Ford, Paolo D A Vignali, Natalie L Rittenhouse, et al.
Cell Reports|February 10, 2018
Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector FunctionsAshley V Menk, Nicole E Scharping, Rebecca S Moreci, et al.
JCI Insight|February 22, 2023
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapyFrank P Vendetti, Pinakin Pandya, David A Clump, et al.
Immunity|August 7, 2016
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell ExhaustionBertram Bengsch, Andy L Johnson, Makoto Kurachi, et al.
Immunity|February 14, 2016
Interleukin-35 Limits Anti-Tumor ImmunityMeghan E Turnis, Deepali V Sawant, Andrea L Szymczak-Workman, et al.
Immunity|September 1, 2019
Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor ClearanceDayana B Rivadeneira, Kristin DePeaux, Yiyang Wang, et al.
Frontiers in Oncology|July 3, 2023
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional studyRyan C Augustin, Ziyu Huang, Fei Ding, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2024
Tim-3 Is Required for Regulatory T Cell-Mediated Promotion of T Cell Exhaustion and Viral Persistence during Chronic Lymphocytic Choriomeningitis Virus InfectionHector M Nieves-Rosado, Hridesh Banerjee, Angela Gocher-Demske, et al.
Pageof 12